Details

---

Manufacturer

Sunward Pharmaceutical Sdn Bhd (Malaysia)

Registraction Number

MAL19900395AZ

Content:

Diclofenac sodium 25 mg per enteric-coated tablet; includes standard excipients for stability and delayed-release formulation

 

Indications

• Indicated for relief of inflammatory and degenerative rheumatism (e.g., rheumatoid arthritis, osteoarthritis, ankylosing spondylitis), non‑articular musculoskeletal pain, acute gout attacks, and primary dysmenorrhoea (menstrual pain)

 

Instructions

• Adults/Adolescents (≥14 yrs): 25–50 mg orally, three times daily, preferably after meals to minimize gastrointestinal irritation; dosage tailored to patient response.

• Enteric‑coated tablet: swallow whole, do not crush or chew; take with food.

• Precautions: contraindicated in NSAID/aspirin hypersensitivity (e.g., asthma, nasal polyps), peptic ulcer, bleeding disorders, severe heart, liver or renal impairment; avoid in pregnancy and lactation; monitor for cardiovascular and gastrointestinal risks